IL1B and COVID-19: Mean plasma levels of IL-1β and IL-18, as products of inflammasome activity and pyroptosis, were higher in COVID-19 than in the other groups (Fig. 1E, F), as was the case for the alveolar cell damage marker sRAGE and GDF15 in the COVID-19 group (Fig. 1G, H).